Valuation: BioNexus Gene Lab Corp.

Market Cap 2.62M 2.34M 2.15M 1.95M 3.7M 245M 3.79M 25.72M 10.25M 131M 9.82M 9.61M 414M P/E 2024
-3.12x
P/E 2025 -2.46x
Enterprise Value -1.2M -1.07M -983K -892K -1.69M -112M -1.73M -11.76M -4.69M -60.05M -4.49M -4.4M -189M EV / Sales 2024
0.09x
EV / Sales 2025 0.74x
Free-Float
55.28%
Yield 2024 *
-
Yield 2025 -
1 day+7.51%
1 week-11.18%
Current month-2.75%
1 month-30.83%
3 months-45.59%
6 months-56.68%
Current year-77.41%
1 week 0.82
Extreme 0.819899
0.94
1 month 0.82
Extreme 0.819899
1.39
Current year 0.82
Extreme 0.819899
4.14
1 year 0.82
Extreme 0.819899
5.15
3 years 0.82
Extreme 0.819899
33.9
5 years 0.82
Extreme 0.819899
267.6
10 years 0.82
Extreme 0.819899
414
Manager TitleAgeSince
Chief Executive Officer 43 2023-12-10
Director of Finance/CFO 63 2025-06-16
Director TitleAgeSince
Director/Board Member 71 2022-03-06
Director/Board Member 43 2023-12-10
Director/Board Member 51 2023-12-10
Date Insider Type Main position Quantity % Market Cap. Importance
8/13/26 Free

Director

32,258 1.0997%
8/13/26 Free

Chief Executive Officer

338,709 11.5465%
8/13/26 Free

Director

16,129 0.5498%
Change 5-day change 1-year change 3-year change Capi.($)
+7.51%-11.18%-82.47%-75.69% 2.43M
+2.24%+8.40%+58.47%+69.00% 66.7B
+4.66%+8.90%+16.93%+85.41% 56.88B
-0.60%+1.73%+24.32%+94.40% 56.53B
+2.55%+15.52%+30.43%+120.17% 46.49B
+2.58%+7.89%+32.49%+45.30% 44.8B
+4.09%+6.37%+228.06%+899.75% 41.59B
-0.47%+9.38%+27.53%+52.40% 35.35B
+3.80%-1.00%+98.16%+66.79% 33.29B
+1.48%+6.21%-38.80%+395.73% 25.1B
Average +2.78%+4.85%+39.51%+175.32% 41B
Weighted average by Cap. +2.29%+7.27%+53.75%+181.55%

Financials

2024 2025
Net sales 9.51M 8.49M 7.81M 7.09M 13.44M 891M 13.77M 93.45M 37.25M 477M 35.7M 34.93M 1.5B 7.42M 6.63M 6.1M 5.53M 10.49M 696M 10.75M 72.95M 29.08M 373M 27.87M 27.27M 1.17B
Net income -1.6M -1.43M -1.31M -1.19M -2.26M -150M -2.31M -15.7M -6.26M -80.21M -6M -5.87M -253M -2.98M -2.66M -2.45M -2.22M -4.22M -280M -4.32M -29.33M -11.69M -150M -11.2M -10.96M -472M
Net Debt -4.15M -3.7M -3.41M -3.09M -5.86M -389M -6.01M -40.77M -16.25M -208M -15.58M -15.24M -656M -3.81M -3.4M -3.13M -2.84M -5.39M -358M -5.52M -37.48M -14.94M -191M -14.32M -14.01M -603M
Projected Income Statement - Annual - BioNexus Gene Lab Corp.
Logo BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
Employees
19
Date Price Change Volume
26-11-09 US$0.8923 +7.51% 4,395
26-11-06 US$0.8300 -3.09% 5,158
26-11-05 US$0.8565 -8.88% 3,298
26-11-04 US$0.9400 -1.05% 5,926
26-11-03 US$0.9500 -5.43% 10,651
  1. Stock Market
  2. Stocks
  3. BGLC Stock